Business Standard
Monday, Feb 13, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 
Ocimum Bio launches new product
Our Regional Bureau / Hyderabad April 10,2004
Ocimum Biosolutions launched on Thursday a new product, iRNAWiz – a comprehensive and intuitive tool for the design of short interfering RNA.
 
Ribonucleic acid (RNA) is a single-stranded nucleic acid made up of nucleotides which are the subunits of a DNA molecule. RNA is involved in the transcription of genetic information. RNA interference (iRNA) is one of the most powerful molecular biology tools with a wide variety of applications.
 
It is the phenomenon in which introduction of a double-stranded RNA (dsRNA) suppresses the expression of the homologous gene. RNA interference (RNAi) is an evolutionarily conserved mechanism in plant and animal cells that directs the degradation of messenger RNAs homologous to short double-stranded RNAs termed small interfering RNA (siRNA).
 
 

 
The success of a RNA interference experiment is heavily dependent on the design of siRNA for specificity and efficiency. siRNAs must be designed against a target region. The regions of interest may be set by eliminating or selecting sequences that define open reading frames (ORFs), untranslated regions (UTRs), motifs/ domains, and introns and exons or Open Reading Frames (ORFs).
 
 

 
Anuradha Acharya, chief executive of Ocimum Biosolutions, stated in a release that iRNAWiz provides a comprehensive and intuitive design environment for the organisation of sequence data and design of siRNAs, and tracking and analysis of successful templates. It provides the user with flexibility to define his own search templates, set regions of interest based of wide variety of criterion like ORFs, UTR regions, introns and exons, secondary structures, motifs and domains, and post design analysis of successful siRNA.
 
 

 
“We are very excited at the release of our niche product iRNAWiz. We believe that scientists will be able to significantly speed up their research in the field of siRNA design. iRNAWiz represents a major step forward in this field of science,” Acharya said. Ocimum plans to launch PharmatrackerTM, a LIMS for the pharmaceutical industry, by the end of the year.
 
 

 
Biosolutions, an ISO 9001:2000 certified life sciences contract R&D company, provides customised contract research services and next generation bioinformatics tools and services in the area of genomics, proteomics, laboratory information management (LIMS) for biotech and pharmaceutical industry. The company’s other products include sequence analysis package GenchekTM; microarray data analysis suite GenowizTM; and, gene optimisation tool OptGeneTM.
 
 

Ocimum Bio launches new product
Our Regional Bureau / Hyderabad Apr 10, 2004, 00:01 IST

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end tad higher
- Arvind Q3 net profit at Rs 243 cr
- Amara Raja Q3 net profit soars 66%
- CIL Q3 consolidated net surges 54% to Rs 4,037 cr
- Eicher Motors Q4 net profit surges 56%
  Read Business news in 
- Now property search gets more exciting than ever before!
- Office 365 for professionals and small businesses.
- Are You Serious About Your Future? Click here to know more
- Financial Learning now made easier and more convenient.
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Get 5% cashback on telephone bills with Citi
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Budget could change provisions to tax international transactions
- Greek drama to set mkt mood
- Some suitors for Gujarat Gas may combine
- Emaar MGF created 10 firms to usurp prime land: CBI
- Gujarat accounts for 10% of total sales of Mahindra`s SUVs
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
Ambassador car |  Uttarakhand |  TCS |  Sarfaesi Act |  Vodafone |  DZire |  Aakash tablet |  Sodexo |  NHAI |  Companies Bill 2011 |  Playbook |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  FDI in retail |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  TCS |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us